Skip Navigation

Facilitating an Expeditious Review and Approval Process

Set up to protect human research subjects, Atrium Health’s Institutional Review Board (IRB) is focused on making the study review-and-approval process one that is rapid, simple and thorough.

IRB operates under the guidance of the Belmont Report, which contains ethical principles and guidelines in relation to research involving human subjects. All sites within Atrium Health conform to ethical principles of the highest standard as determined by the U.S. Department of Health and Human Services and the Office for Civil Rights.

Partnering with Advarra – an AAHRPP-accredited commercial IRB organization that reviews full board studies – we provide our investigators, industry sponsors and government sponsors with an approval process characterized by the following benefits:

  • Review of complete submissions within one week
  • Four-day protocol review
  • 24-hour site review
  • Accessibility of approved documents within 24 hours
  • An IRB team that meets daily
  • Single review and approval for studies occurring at multiple Atrium Health facilities
  • Secure access of projects online anywhere, anytime
  • Fully validated 21 CFR Part 11 (part of Title 21 of the Code of Federal Regulations) system that ensures security
  • Real-time project status updates
  • Site metrics that assist in critical decision-making

Sponsor Information

Atrium Health’s IRB complies with all federal regulations pertaining to the protection of human research subjects. Atrium Health has a Federal Wide Assurance (FWA) and is registered with the Office for Human Research Protections.

FWA: 00000387 IORG: 0000740
IRB registration: 00001088

Contact Information:
Staff Assistant
Atrium Health’s Institutional Review Board